» Articles » PMID: 31776247

Combined HIV-1 Sequence and Integration Site Analysis Informs Viral Dynamics and Allows Reconstruction of Replicating Viral Ancestors

Abstract

Understanding HIV-1 persistence despite antiretroviral therapy (ART) is of paramount importance. Both single-genome sequencing (SGS) and integration site analysis (ISA) provide useful information regarding the structure of persistent HIV DNA populations; however, until recently, there was no way to link integration sites to their cognate proviral sequences. Here, we used multiple-displacement amplification (MDA) of cellular DNA diluted to a proviral endpoint to obtain full-length proviral sequences and their corresponding sites of integration. We applied this method to lymph node and peripheral blood mononuclear cells from 5 ART-treated donors to determine whether groups of identical subgenomic sequences in the 2 compartments are the result of clonal expansion of infected cells or a viral genetic bottleneck. We found that identical proviral sequences can result from both cellular expansion and viral genetic bottlenecks occurring prior to ART initiation and following ART failure. We identified an expanded T cell clone carrying an intact provirus that matched a variant previously detected by viral outgrowth assays and expanded clones with wild-type and drug-resistant defective proviruses. We also found 2 clones from 1 donor that carried identical proviruses except for nonoverlapping deletions, from which we could infer the sequence of the intact parental virus. Thus, MDA-SGS can be used for "viral reconstruction" to better understand intrapatient HIV-1 evolution and to determine the clonality and structure of proviruses within expanded clones, including those with drug-resistant mutations. Importantly, we demonstrate that identical sequences observed by standard SGS are not always sufficient to establish proviral clonality.

Citing Articles

Immune-mediated strategies to solving the HIV reservoir problem.

Kulpa D, Paiardini M, Silvestri G Nat Rev Immunol. 2025; .

PMID: 39948261 DOI: 10.1038/s41577-025-01136-7.


A simple phylogenetic approach to analyze hypermutated HIV proviruses reveals insights into their dynamics and persistence during antiretroviral therapy.

Shahid A, Jones B, Duncan M, MacLennan S, Dapp M, Kuniholm M Virus Evol. 2025; 11(1):veae094.

PMID: 39802824 PMC: 11724191. DOI: 10.1093/ve/veae094.


Comparing acute versus AIDS ART initiation on HIV-1 integration sites and clonal expansion.

Wang J, Xiao N, Zhu Z, Qiao H, Zhao F, Zhang L Signal Transduct Target Ther. 2025; 10(1):23.

PMID: 39788938 PMC: 11718275. DOI: 10.1038/s41392-024-02113-7.


Distinguishable topology of the task-evoked functional genome networks in HIV-1 reservoirs.

Wisniewski J, Wiecek K, Ali H, Pyrc K, Kula-Pacurar A, Wagner M iScience. 2024; 27(11):111222.

PMID: 39559761 PMC: 11570469. DOI: 10.1016/j.isci.2024.111222.


A simple phylogenetic approach to analyze hypermutated HIV proviruses reveals insights into their dynamics and persistence during antiretroviral therapy.

Shahid A, Jones B, Duncan M, MacLennan S, Dapp M, Kuniholm M Res Sq. 2024; .

PMID: 38947061 PMC: 11213167. DOI: 10.21203/rs.3.rs-4549934/v1.


References
1.
Clouse K, Powell D, Washington I, Poli G, Strebel K, Farrar W . Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J Immunol. 1989; 142(2):431-8. View

2.
Favre D, Stoddart C, Emu B, Hoh R, Martin J, Hecht F . HIV disease progression correlates with the generation of dysfunctional naive CD8(low) T cells. Blood. 2011; 117(7):2189-99. PMC: 3062328. DOI: 10.1182/blood-2010-06-288035. View

3.
Martin A, Siliciano R . Progress Toward HIV Eradication: Case Reports, Current Efforts, and the Challenges Associated with Cure. Annu Rev Med. 2015; 67:215-28. DOI: 10.1146/annurev-med-011514-023043. View

4.
Cohn L, da Silva I, Valieris R, Huang A, Lorenzi J, Cohen Y . Clonal CD4 T cells in the HIV-1 latent reservoir display a distinct gene profile upon reactivation. Nat Med. 2018; 24(5):604-609. PMC: 5972543. DOI: 10.1038/s41591-018-0017-7. View

5.
Varadarajan J, McWilliams M, Hughes S . Treatment with suboptimal doses of raltegravir leads to aberrant HIV-1 integrations. Proc Natl Acad Sci U S A. 2013; 110(36):14747-52. PMC: 3767498. DOI: 10.1073/pnas.1305066110. View